Acute Anaphylaxis Clinical Care Standard

The National Allergy Strategy is proud to have supported the development of the Acute Anaphylaxis Clinical Care Standard.

The Acute Anaphylaxis Clinical Care Standard is underpinned by ASCIA’s guidelines for the acute management of anaphylaxis. We believe the Acute Anaphylaxis Clinical Care Standard will help improve emergency treatment of anaphylaxis in Australia whether it is being managed in a hospital or in the community by paramedics or general practitioners.

The Acute Anaphylaxis Clinical Care Standard also ensures that the patient’s needs are supported allowing patients to have easy access to their adrenaline injectors when in hospital and most importantly, provided with education, support and referrals they need when they are discharged after anaphylaxis.

The new discharge checklist will help standardise discharge information across Australian hospitals and make sure patients are provided with an adrenaline injector prescription, and where possible, dispensed adrenaline injector devices before being discharged from hospital. The discharge checklist will also make sure patients are educated about how and when to use their adrenaline injector and that they are provided with an ASCIA Action Plan for Anaphylaxis.

The Acute Anaphylaxis Clinical Care Standard will also help connect patients with Allergy & Anaphylaxis Australia where trained health educators can share information, provide support and help them with day-to-day management of their severe allergy as they wait to see their doctor.

The Acute Anaphylaxis Clinical Care Standard includes several resources developed by the National Allergy Strategy to help improve anaphylaxis management. These include images and a link to an animation about how to position a person experiencing anaphylaxis and also a link to an animation about how to safely remove ticks.

Visit the Australian Commission on Safety and Quality in Health Care website for more information about the Acute Anaphylaxis Clinical Care Standard.

 

Anaphylaxis in Australia

Acute Anaphylaxis Clinical Care Standard - Anaphylaxis in Australia

Content created November 2021

The National Allergy Council remains a partnership between ASCIA and Allergy & Anaphylaxis Australia and continues to implement the National Allergy Strategy.

National Allergy Strategy
Rationale

Allergic diseases have become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades, contributing to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic diseases and their carers.

Information
Partner

healthdirect: 
trusted health information
Funded by the governments of Australia

Lead organisations

ascia logo 2018s
Australasian Society of Clinical Immunology and Allergy (ASCIA) is the leading medical organisation for allergy in Australia. 

aaa logo 2018s
Allergy & Anaphylaxis Australia (A&AA) is the leading patient support organisation for allergy in Australia. 

The National Allergy Strategy has received funding from the Australian Government Department of Health for the following projects:
Food allergy prevention | 250K Youth Project | Food service | Drug allergy | Shared Care Model

© National Allergy Strategy Aug 2015 | Contact Us | Disclaimer | Food Allergy Training Help | Privacy | Sitemap

Acknowledgement of Country
The National Allergy Council acknowledges the Traditional Custodians of the land upon which we are located. We pay our respect to their Elders past, present and emerging.